Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Filipa Lynce, M.D.

Concepts (175)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Breast Neoplasms520241314.000 Why?
Breast Neoplasms302024206152.040 Why?
BRCA2 Protein820247931.520 Why?
BRCA1 Protein8202411411.450 Why?
Receptor, erbB-28202223651.410 Why?
Paclitaxel3202416981.060 Why?
Pyrazoles2202419580.840 Why?
Nitriles220249480.800 Why?
Antineoplastic Combined Chemotherapy Protocols82024113950.750 Why?
Ovarian Neoplasms4202348140.750 Why?
Platinum120212290.700 Why?
Antineoplastic Agents82022136380.660 Why?
Ventricular Dysfunction, Left2201920260.600 Why?
Neoadjuvant Therapy8202426520.570 Why?
Anthracyclines320202830.560 Why?
Clinical Trials, Phase I as Topic120173150.560 Why?
Neutropenia120218860.550 Why?
Angiotensin-Converting Enzyme Inhibitors2201915020.510 Why?
Pyrimidines2202429060.500 Why?
Central Nervous System Neoplasms120228890.480 Why?
Medically Underserved Area120152530.460 Why?
Adrenergic beta-Antagonists1201912280.450 Why?
Molecular Targeted Therapy3201927350.440 Why?
Genes, BRCA2120156170.420 Why?
Genes, BRCA1120157790.400 Why?
Vulnerable Populations120156810.360 Why?
Genetic Testing4202434750.350 Why?
Troponin I220176150.350 Why?
Troponin T220177520.340 Why?
Patient Selection3202142220.330 Why?
Maytansine22019790.310 Why?
Cyclin-Dependent Kinase 6220223230.310 Why?
Female4020243785100.310 Why?
Urban Population1201520100.300 Why?
Ovariectomy220206650.270 Why?
Humans4820247369400.250 Why?
Immunoconjugates220228700.250 Why?
Population Surveillance1201526520.250 Why?
Lymphoma1201118750.220 Why?
Protein Kinase Inhibitors1201854990.210 Why?
Angiogenesis Inhibitors1201220400.200 Why?
Mutation72022298440.200 Why?
Weight Gain1201122770.200 Why?
Survivors1201122610.200 Why?
Omeprazole120211120.190 Why?
Phthalazines120233570.190 Why?
Poly(ADP-ribose) Polymerases120234410.190 Why?
Neoplasms32019214100.190 Why?
Receptors, Estrogen3202221690.180 Why?
Lisinopril12019530.180 Why?
Neoplasm Staging62020109680.170 Why?
Genetic Predisposition to Disease32024174190.170 Why?
Urogenital System12019840.170 Why?
Piperazines2202124740.170 Why?
Prognosis42023289670.170 Why?
Cyclin-Dependent Kinase 4220225310.170 Why?
Germ-Line Mutation2202418010.160 Why?
Estrogen Receptor alpha120225790.160 Why?
Neoplasm Recurrence, Local5202491290.160 Why?
Pyridines2202128090.160 Why?
Camptothecin120215580.160 Why?
Antimetabolites, Antineoplastic120216410.160 Why?
Carboplatin120218010.160 Why?
Cardiac Imaging Techniques120202670.150 Why?
Maximum Tolerated Dose120198870.150 Why?
Genetic Counseling220236040.140 Why?
National Cancer Institute (U.S.)120172810.140 Why?
Middle Aged1720212131150.140 Why?
Antibiotics, Antineoplastic120206910.140 Why?
Aged1220211626790.140 Why?
Adult1620212132830.140 Why?
District of Columbia120151570.130 Why?
Central Nervous System1202213420.130 Why?
Purines120185930.130 Why?
Cell Adhesion Molecules1202116060.130 Why?
Neoplasms, Second Primary1202210410.130 Why?
Mastectomy1202317700.130 Why?
Aminopyridines120185400.120 Why?
Genetic Heterogeneity120187290.120 Why?
Jews120163850.120 Why?
DNA Copy Number Variations1202319710.120 Why?
Retrospective Studies62023762000.120 Why?
Treatment Outcome72024625010.120 Why?
Breast1202319260.120 Why?
Interleukin-61202431940.120 Why?
Endometrial Neoplasms1202313620.120 Why?
Neoplastic Cells, Circulating120209100.120 Why?
Benzimidazoles120188500.110 Why?
RNA1202327420.110 Why?
Estrogens1201915640.100 Why?
Radiation Injuries1201911570.100 Why?
Time Factors52021401310.100 Why?
Disease-Free Survival3202168920.100 Why?
Ventricular Function, Left3202136020.090 Why?
Neoplasm Metastasis1202148530.090 Why?
Germ Cells220246330.090 Why?
Obesity12011126530.090 Why?
Aged, 80 and over52021577380.090 Why?
Hippocratic Oath12008150.080 Why?
Risk Reduction Behavior1201511230.080 Why?
Young Adult62020562390.080 Why?
Heart Diseases1202027820.070 Why?
Dose-Response Relationship, Drug12019109580.070 Why?
DNA Repair1201620260.070 Why?
Pilot Projects1201982590.070 Why?
Chemotherapy, Adjuvant3202034570.070 Why?
Drug Approval120127400.070 Why?
Heart Failure12008107030.060 Why?
Echocardiography1201750980.060 Why?
Incidence12022208830.060 Why?
Registries2202080160.060 Why?
Risk1201697040.060 Why?
Heart1201744570.060 Why?
Pamphlets12023750.060 Why?
Neoplasm Proteins1201637080.060 Why?
Risk Assessment42024232980.060 Why?
Age Factors32017183590.050 Why?
Stroke Volume3202149080.050 Why?
Review Literature as Topic120233250.050 Why?
Gene Expression Profiling1201794210.050 Why?
Body Weight1201146660.050 Why?
Genomics1201656820.050 Why?
Evidence-Based Medicine1201236130.040 Why?
Telephone120236200.040 Why?
Prevalence12016151250.040 Why?
Risk Factors52023717840.040 Why?
Administration, Intravaginal120191470.040 Why?
Taxoids120226580.040 Why?
Animals320181687350.040 Why?
Aromatase Inhibitors120224900.040 Why?
Male620213490250.040 Why?
Sex Factors12011103860.040 Why?
Ubiquitin Thiolesterase120204550.040 Why?
High-Throughput Nucleotide Sequencing2202136420.040 Why?
Prospective Studies22019528060.040 Why?
Neoplasm, Residual120219760.040 Why?
Quality of Life22022125090.040 Why?
Logistic Models12011134080.040 Why?
Receptors, Androgen1202210400.030 Why?
United States32020693620.030 Why?
Diarrhea1202213520.030 Why?
Ligands1202233180.030 Why?
Tumor Burden1202119070.030 Why?
Early Diagnosis1202011780.030 Why?
Predictive Value of Tests22021150790.030 Why?
Atrophy1201915690.030 Why?
Body Mass Index12011126350.030 Why?
Gynecology120195030.030 Why?
Cardiovascular Diseases12019149680.030 Why?
Sensitivity and Specificity12008147380.030 Why?
Qualitative Research1202226390.030 Why?
Antigens, Neoplasm1202119640.030 Why?
Adolescent22020852250.030 Why?
Health Care Surveys1201924510.030 Why?
Radiotherapy1201915300.030 Why?
DNA Damage1202024220.020 Why?
Caregivers1202220410.020 Why?
Tumor Suppressor Proteins1202028620.020 Why?
Doxorubicin1201622150.020 Why?
DNA Mutational Analysis1201842330.020 Why?
Mutation, Missense1201825530.020 Why?
Immunotherapy1202443500.020 Why?
Survival Analysis12021102610.020 Why?
Health Status Disparities1201817690.020 Why?
Kaplan-Meier Estimate1201765350.020 Why?
Drug Resistance, Neoplasm1202151520.020 Why?
Medication Adherence1201720410.020 Why?
Recurrence1201782910.020 Why?
Databases, Factual1202077110.020 Why?
Health Knowledge, Attitudes, Practice1201939000.020 Why?
Odds Ratio1201798600.020 Why?
Physicians1201945200.010 Why?
Follow-Up Studies12021389370.010 Why?
Cross-Sectional Studies12019245980.010 Why?
Cohort Studies12018402930.010 Why?
Lynce's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (175)
Explore
_
Co-Authors (51)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.